Insider Transactions in Q4 2025 at Oric Pharmaceuticals, Inc. (ORIC)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2025
|
Dominic Piscitelli Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,720
-13.59%
|
$96,480
$9.06 P/Share
|
|
Dec 16
2025
|
Pratik S Multani Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,720
-13.59%
|
$96,480
$9.06 P/Share
|
|
Dec 16
2025
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
33,374
-5.43%
|
$300,366
$9.06 P/Share
|
|
Dec 15
2025
|
Dominic Piscitelli Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,333
+27.11%
|
-
|
|
Dec 15
2025
|
Pratik S Multani Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,333
+27.11%
|
-
|
|
Dec 15
2025
|
Jacob Chacko PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
83,666
+11.97%
|
-
|
|
Dec 08
2025
|
Lori Anne Kunkel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.62%
|
$70,000
$7.9 P/Share
|
|
Dec 04
2025
|
Lori Anne Kunkel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,534
+6.94%
|
$16,602
$3.75 P/Share
|
|
Oct 06
2025
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
37,461
-6.59%
|
$449,532
$12.32 P/Share
|
|
Oct 06
2025
|
Dominic Piscitelli Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,000
-18.54%
|
$154,000
$14.52 P/Share
|
|
Oct 06
2025
|
Dominic Piscitelli Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+15.64%
|
$44,000
$4.36 P/Share
|
|
Oct 03
2025
|
Richard A. Heyman |
BUY
Exercise of conversion of derivative security
|
Direct |
32,800
+22.39%
|
$65,600
$2.68 P/Share
|
|
Oct 01
2025
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
53,001
-8.52%
|
$636,012
$12.05 P/Share
|